|
C9ORF100 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.468600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.641800E-01 |
| Normal-vs-Stage2 |
1.555400E-01 |
| Normal-vs-Stage3 |
9.297800E-01 |
| Normal-vs-Stage4 |
2.464400E-01 |
| Stage1-vs-Stage2 |
8.764300E-02 |
| Stage1-vs-Stage3 |
9.452000E-01 |
| Stage1-vs-Stage4 |
1.014370E-01 |
| Stage2-vs-Stage3 |
1.090220E-01 |
| Stage2-vs-Stage4 |
9.423500E-03 |
| Stage3-vs-Stage4 |
1.252210E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.912000E-01 |
| Normal-vs-AfricanAmerican |
8.131400E-01 |
| Normal-vs-Asian |
6.795600E-01 |
| Caucasian-vs-AfricanAmerican |
8.481200E-01 |
| Caucasian-vs-Asian |
7.088200E-01 |
| AfricanAmerican-vs-Asian |
9.402600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.578800E-01 |
| Normal-vs-Female |
6.845800E-01 |
| Male-vs-Female |
7.404000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.978400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.522600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.019600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.662600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.662100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.493000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.564400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.726400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.900960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.468000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.816600E-01 |
| Classical-VS-Follicular |
5.984400E-01 |
| Classical-VS-Other |
6.604800E-01 |
| Classical-VS-Normal |
8.754200E-01 |
| Tall-VS-Follicular |
7.290800E-01 |
| Tall-VS-Other |
8.889800E-01 |
| Tall-VS-Normal |
6.172400E-01 |
| Follicular-VS-Other |
7.966000E-01 |
| Follicular-VS-Normal |
8.254200E-01 |
| Other-VS-Normal |
5.846800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.563000E-01 |
| Normal-vs-N1 |
8.406200E-01 |
| N0-vs-N1 |
7.722200E-01 |
|
|
